BRAF and melanoma: In human melanomas, no correlation was observed between TBX2 expression and activating mutation of BRAF or NRAS, but, in contrast, inactivation of PTEN correlated with elevated TBX2 expression compared with tumors expressing WT PTEN (Fig. 1F).